CD19 and plasma cell myeloma: Moreover, it was recently reported that dual CD19- and BCMA-CAR-T cells were able to completely ablate regulatory B-cells from the bone marrow of MM patients, contributing to a favorable environment for clearance of myeloma cells in the bone marrow [25].